HomeCSTL • NASDAQ
add
Castle Biosciences Inc
Previous close
$28.00
Day range
$27.81 - $28.39
Year range
$12.07 - $32.53
Market cap
772.75M USD
Avg Volume
352.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 87.00M | 73.53% |
Operating expense | 67.47M | 12.01% |
Net income | 8.92M | 147.50% |
Net profit margin | 10.25 | 127.37% |
Earnings per share | 0.31 | 144.29% |
EBITDA | 8.36M | 146.14% |
Effective tax rate | -13.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 259.69M | 15.16% |
Total assets | 487.31M | 14.55% |
Total liabilities | 63.42M | 36.00% |
Total equity | 423.89M | — |
Shares outstanding | 27.74M | — |
Price to book | 1.83 | — |
Return on assets | 2.65% | — |
Return on capital | 2.86% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 8.92M | 147.50% |
Cash from operations | 24.00M | 733.86% |
Cash from investing | -21.42M | -39.19% |
Cash from financing | 42.00K | -81.42% |
Net change in cash | 2.62M | 113.84% |
Free cash flow | 17.57M | 806.95% |
About
Founded
2007
Headquarters
Website
Employees
703
